About Vycor Medical
Vycor Medical is a publicly listed company based in Boca Raton (United States) founded in 2005. Minimally invasive devices and therapies for neurological conditions are developed. The company has 7 employees. Vycor Medical offers products and services including ViewSite Brain Access System and NovaVision. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is VYCOR MEDICAL INC. Its competitors include Zeta Surgical, Q’Apel Medical and CalmiGo; 2 of its 3 listed competitors have raised funding.
Company details
Vycor Medical operates two distinct business units, Vycor Medical and NovaVision. Vycor medical segment develops medical devices for use in neurosurgery. NovaVision provides solutions for people who have visual field deficit resulting from a neurological trauma such as stroke or traumatic brain injury (TBI). Their main offerings are ViewSite Brain Access System (VBAS), a transparent cylindrical disposable device used to provide surgical access to sites within the brain for tumour removal; NovaVision Vision Restoration Therapy (VRT) Sight Science Neuro-Eye Therapy (NeET) - are a restoration therapies aimed at improving visual sensitivity in the previously blind zones by repeated stimulation. NovaVision NeuroEyeCoach (NEC) - is a complementary therapy to VRT and NeET which re-trains ability of a patient to move their eyes, re-integrate left and right vision and to make the most of their remaining visual field. They went public in 2009.
- Annual Revenue$1.86 M (USD)17.24as on Dec 31, 2025
- Net Profit-$72.43 K (USD)32.44as on Dec 31, 2025
- EBITDA$97.04 K (USD)77.18as on Dec 31, 2025
- Latest Funding Round$618.61K (USD), Post-IPO
Jan 2017
- Employee Count7
Products & Services of Vycor Medical
Vycor Medical offers a comprehensive portfolio of products and services, including ViewSite Brain Access System and NovaVision.
Provides surgical corridors for brain tumor access during procedures.
Offers computer-based diagnostics and therapies for vision loss from brain injuries.
Apps and channels of Vycor Medical
its YouTube channel Vycor Medical has 97 subscribers and 23 videos.
Videos from Vycor Medical
The most watched videos on Vycor Medical's YouTube channel, Vycor Medical (97 subscribers). Click a video to play it here.
More on Vycor Medical.
Funding Insights of Vycor Medical
- Total Rounds 5
- Last Round Post-IPO — $618,607
- First Round $2.95M
(Jan 2010)
All 5 funding rounds of Vycor Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $618,607 | Post-IPO | – | – | – |
| May 2014 | $5M | Post-IPO | – | – | – |
| Nov 2011 | $3M | Post-IPO | – | – | – |
| Sep 2011 | $190,000 | Post-IPO | – | – | – |
| Jan 2010 | $2.95M | Post-IPO | – | – | – |
People of Vycor Medical
1 people are tracked at Vycor Medical (1 in leadership); the tracked headcount is 7.
| Name | Role | Group |
|---|---|---|
Peter Zachariou | Chief Executive Officer | Leadership |
Complete people profiles for Vycor Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Vycor Medical
Vycor Medical is a publicly listed company on the OTC with ticker symbol VYCO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Mar 2015
- Listed onOTCMKTS: VYCO
- Listed entityVycor Medical, Inc.
- Exchange sectorHealth technology
- ISINUS92921M2035
- Share price$0.07 (+1.62% on the day) · 2026-05-11
- Market capitalisation$2.3M
- EPS (diluted, trailing year)$-0.01
- Volume (last session)10,000
- Analyst consensusNo rating
Financials of Vycor Medical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.9M | -$72,430 | $97,040 |
| 2024 | $1.6M | -$107,200 | $54,770 |
| 2023 | $1.5M | -$69,690 | $100,940 |
| 2022 | $1.2M | -$404,920 | -$245,110 |
| 2021 | $1.4M | -$435,660 | -$367,530 |
Detailed financial statements for Vycor Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Vycor Medical
4 dated milestones of Vycor Medical across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Vycor Medical is founded.
- Funding First funding round of $3.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $619K.
Competitors of Vycor Medical
Vycor Medical has 3 listed competitors in our database, 2 of them funded. They include Zeta Surgical, Q’Apel Medical and CalmiGo.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zetasurgical.com | 2016 | Boston, United States | $8.16M | 7 | AI-based navigation and robotics systems for surgeries are developed. | |
| qapelmedical.com | 2019 | Fremont, United States | $51.9M | 100 | Medical devices for neurovascular disorder treatments are provided. | |
| calmigo.com | 2010 | New York, United States | Stress-relief devices are developed using smart breathing regulation technology. |
Detailed competitors of Vycor Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Vycor Medical
The website of Vycor Medical (vycormedical.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 17.4% vs previous month
Websites whose visitors overlap most with Vycor Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mizuho.com | 100% | 4.2K | #4,467,769 | View details |
Top companies in Neurology
3 companies that operate in the same segment as Vycor Medical (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vycor Medical
Complete news archive for Vycor Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vycor Medical
Vycor Medical was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Vycor Medical is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Vycor Medical has 7 employees.
Annual revenue of Vycor Medical is $1.86M as on Dec 31, 2025.
Vycor Medical operates two distinct business units, Vycor Medical and NovaVision. Vycor medical segment develops medical devices for use in neurosurgery. NovaVision provides solutions for people who have visual field deficit resulting from a neurological trauma such as stroke or traumatic brain injury (TBI). Their main offerings are ViewSite Brain Access System (VBAS), a transparent cylindrical disposable device used to provide surgical access to sites within the brain for tumour removal; NovaVision Vision Restoration Therapy (VRT) Sight Science Neuro-Eye Therapy (NeET) - are a restoration therapies aimed at improving visual sensitivity in the previously blind zones by repeated stimulation. NovaVision NeuroEyeCoach (NEC) - is a complementary therapy to VRT and NeET which re-trains ability of a patient to move their eyes, re-integrate left and right vision and to make the most of their remaining visual field. They went public in 2009.
Vycor Medical's top competitors include Zeta Surgical, Q’Apel Medical and CalmiGo.
Vycor Medical offers ViewSite Brain Access System and NovaVision.
Yes, Vycor Medical is publicly traded on OTC under the ticker symbol VYCO.
Vycor Medical operates through Vycor Medical Inc.